Medpace Holdings, Inc.MEDPNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

14 analysts·Moderate coverage

21%

Rating Distribution

Strong Buy

00%

Buy

321%

Hold

857%

Sell

321%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case

$525.00

-10%

Consensus

$588.25

+1%

Bull Case

$660.00

+13%

Price Range14 analysts

Low

Consensus

High

$525.00

$660.00

Current Target

Current Price

$582.48

Upside to Target

$5.77

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$16.64(8 analysts)

P/E39x

Current: 39.1x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+8.49%

EPS+12.16%

FY2028

Rev+8.81%

EPS+12.05%

FY2029

Rev+14.48%

EPS+11.67%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+14.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 9, 2026Mizuho Securities

Medpace price target raised to $660 from $655 at Mizuho

Target:$660.00

+10.0%from $600.02

Dec 15, 2025Barclays

Medpace price target raised to $525 from $485 at Barclays

Target:$525.00

-5.9%from $557.78

Oct 27, 2025Truist Financial

Medpace price target raised to $555 from $436 at Truist

Target:$555.00

-8.3%from $605.20

Oct 24, 2025Robert W. Baird

Medpace price target raised to $613 from $491 at Baird

Target:$613.00

+2.7%from $596.61

Oct 24, 2025Mizuho Securities

Medpace price target raised to $655 from $575 at Mizuho

Target:$655.00

+9.6%from $597.45

Oct 17, 2025Mizuho Securities

Medpace price target raised to $575 from $510 at Mizuho

Target:$575.00

+10.3%from $521.21

Oct 2, 2025Barclays

Medpace downgraded to Underweight from Equal Weight at Barclays

Target:$425.00

-21.9%from $543.90

Mar 24, 2025Leerink Partners

Medpace initiated with a Market Perform at Leerink

Target:$330.00

-0.2%from $330.59

Oct 23, 2024Robert W. Baird

Baird Downgrades Medpace (MEDP) to Neutral

Target:$349.00

+6.9%from $326.54

Sep 25, 2024Jefferies

Medpace downgraded to Hold from Buy at Jefferies

Target:$345.00

-3.0%from $355.82

Aug 1, 2024Truist Financial

Medpace initiated with a Hold at Truist

Target:$415.00

+8.5%from $382.52

Jul 8, 2024Robert W. Baird

Medpace (MEDP) PT Raised to $469 at Baird

Target:$469.00

+16.1%from $404.13

Jun 13, 2024Robert W. Baird

Medpace (MEDP) PT Raised to $456 at Baird

Target:$456.00

+12.9%from $403.74

May 28, 2024Mizuho Securities

Mizuho Starts Medpace (MEDP) at Buy

Target:$435.00

+11.4%from $390.55

Apr 23, 2024Jefferies

Jefferies Upgrades Medpace (MEDP) to Buy

Target:$450.00

+19.6%from $376.26

Feb 15, 2024UBS

UBS Upgrades Medpace (MEDP) to Buy

Target:$452.00

+14.6%from $394.34

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance